Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer.
Vincent van der Noort, Aafke H Honkoop, Jolien Tol, Linda Mol, Aart Beeker, Agnes Jager, Gabe S Sonke, Joan B Heijns, Suzan Vrijaldenhoven, Annemiek van Ommen-Nijhof, Noor Wortelboer, Astrid C P Swinkels, Hedwig M Blommestein, Cristina Guerrero Paez, Karin Beelen, Lisanne C Hamming, Paul C de Jong, Quirine C van Rossum-Schornagel, Christa van Schaik-van de Mheen, Cathrien S Tromp-van Driel, A Elise van Leeuwen-Stok, Inge R Konings
Nature 2024;636(8042):474-480